BOSTON--(BUSINESS WIRE)--Karuna Therapeutics, Inc. (NASDAQ: KRTX), a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions, today announced that management will present at the Goldman Sachs 44^th Annual Global Healthcare Conference on Monday, June 12, 2023, at 2:40 p.m. PT (5:40 p.m. ET).

A live webcast of the presentation will be available on the Investor Relations page of Karuna's website at investors.karunatx.com. A replay of the webcast will also be archived for up to 30 days on Karuna's website following the completion of the event.

More on Boston Chron

• Sidow Sobrino Announces 12th Album, "Seminal"
• Boston Public Health Commission Encourages People to Get the Flu Shot Ahead of Flu Season
• Asha Therapeutics Selected as a BLUE KNIGHT™ Company by Johnson & Johnson Innovation and the Biomedical Advanced Research and Development Authority (BARDA)
• Heartland Soccer Association and VidSport Launch Groundbreaking Live Streaming Service at Garmin Olathe Soccer Complex
• Massachusetts Wins Proposal to Host Northeast Microelectronics Hub through Federal CHIPS and Science Act

About Karuna
Karuna Therapeutics is a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions. At Karuna, we understand there is a need for differentiated and more effective treatments that can help patients navigate the challenges presented by these severe and disabling disorders. Utilizing our extensive knowledge of neuroscience, we are harnessing the untapped potential of the brain in pursuit of novel pathways to develop medicines that make meaningful differences in peoples' lives. For more information, please visit www.karunatx.com.

Contacts

Investors:
Alexis Smith
+1 (518) 338-8990
asmith@karunatx.com

Media:
Bob Josefsberg
+1 (646) 734-3584
bjosefsberg@karunatx.com

---

Show All News | Report Violation